Kilitch Drugs India Ltd - 524500 - Updates On Ethiopian Manufacturing Facility.
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 we hereby informing about the updates on Ethiopian Manufacturing Facility. KILITCH DRUGS (INDIA) LTD. - 524500 - Book Closure For The Purpose Of 27Th AGM & Declaration Of Dividend.
The Register of Members and Share Transfer Books of the Company shall remain closed from Tuesday, September 24th, 2019 to Monday, September 30th, 2019 (both days inclusive) pursuant to regulation 42 of the SEBI (Lisitng Obligation and Disclosure Requirements) Regulations, 2015 for the purpose of 27th AGM and declaration of dividend also. Kilitch Drugs India Ltd - 524500 - Book Closure For The Purpose Of 27Th AGM & Declaration Of Dividend.
The Register of Members and Share Transfer Books of the Company shall remain closed from Tuesday, September 24th, 2019 to Monday, September 30th, 2019 (both days inclusive) pursuant to regulation 42 of the SEBI (Lisitng Obligation and Disclosure Requirements) Regulations, 2015 for the purpose of 27th AGM and declaration of dividend also. KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 KILITCH DRUGS (INDIA) LTD. - 524500 - Outcome of Board Meeting
Outcome of Board Meeting held on August 22nd, 2019 KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for Intimation Of Board Meeting
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2019 ,inter alia, to consider and approve 1. To approve the Directors' Report, Corporate Governance Report of the Company along with all the annexure thereof for financial year 2018-2019 . 2. To finalise the date, venue and time for convening 27th Annual General Meeting of the Company. 3. To finalize the dates of Book Closure for the purpose of forthcoming 27th Annual General Meeting of the Company. 4. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 27th Annual General Meeting. 5. To consider the allotment of Equity shares pursuant to exercise of option granted to employees of the company under ESOS scheme. 6. Any other matter with the permission of the chair. Kilitch Drugs India Ltd - 524500 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company.
With reference to announcement made by your good office, we wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. Therefore, the movement in the share price of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such movement in price. You are requested to take the same on your record. Kilitch Drugs India Ltd - 524500 - Clarification sought from Kilitch Drugs India Ltd
The Exchange has sought clarification from Kilitch Drugs India Ltd on August 13, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclosed herewith our Press Release relating to advisory for improved financial performance in FY 2019-20. Kilitch Drugs India Ltd - 524500 - Outcome of Board Meeting
Outcome of Board Meeting held on August 13, 2019